CA2026030A1 - Maltodextrin/defoaming composition combinate - Google Patents

Maltodextrin/defoaming composition combinate

Info

Publication number
CA2026030A1
CA2026030A1 CA2026030A CA2026030A CA2026030A1 CA 2026030 A1 CA2026030 A1 CA 2026030A1 CA 2026030 A CA2026030 A CA 2026030A CA 2026030 A CA2026030 A CA 2026030A CA 2026030 A1 CA2026030 A1 CA 2026030A1
Authority
CA
Canada
Prior art keywords
defoaming
combinate
maltodextrin
weight percent
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2026030A
Other languages
French (fr)
Other versions
CA2026030C (en
Inventor
William Valentine
William K. Valentine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Technology Pharmaceuticals Corp
Original Assignee
Valentine Enterprises Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentine Enterprises Inc filed Critical Valentine Enterprises Inc
Publication of CA2026030A1 publication Critical patent/CA2026030A1/en
Application granted granted Critical
Publication of CA2026030C publication Critical patent/CA2026030C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/02—Foam dispersion or prevention
    • B01D19/04—Foam dispersion or prevention by addition of chemical substances
    • B01D19/0404—Foam dispersion or prevention by addition of chemical substances characterised by the nature of the chemical substance

Abstract

A defoaming or antifoaming composition comprises a free flowing granular combinate of 50 to 90 weight percent of a water soluble agglomerated maltodextrin and about 10 to 50 weight percent of a fluid, nonaqueous, defoaming or antifoaming composition of a hydrocarbon or silicone oil containing silica, such as simethicone. The composition may be combined with one or more suitable excipients and prepared as a unit dosage in the form of a compressed tablet, filled capsule, or granule for human consumption in pharmaceutical or medicinal applications.
CA002026030A 1989-10-19 1990-09-24 Maltodextrin/defoaming composition combinate Expired - Fee Related CA2026030C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US423,877 1989-10-19
US07/423,877 US5073384A (en) 1989-10-19 1989-10-19 Maltodextrin/defoaming composition combinate

Publications (2)

Publication Number Publication Date
CA2026030A1 true CA2026030A1 (en) 1991-04-20
CA2026030C CA2026030C (en) 1997-04-01

Family

ID=23680536

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002026030A Expired - Fee Related CA2026030C (en) 1989-10-19 1990-09-24 Maltodextrin/defoaming composition combinate

Country Status (6)

Country Link
US (1) US5073384A (en)
EP (1) EP0425450B1 (en)
JP (1) JPH0815521B2 (en)
AT (1) ATE125170T1 (en)
CA (1) CA2026030C (en)
DE (1) DE69021007T2 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275822A (en) * 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
DE4140116A1 (en) * 1991-12-05 1993-06-09 Bolder Arzneimittel Gmbh DIMETICON PASTILLES
GR1002332B (en) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Novel simethicone containing pharmaceutical compositions.
FR2705966B1 (en) * 1993-06-04 1995-08-25 Dow Corning Sa Antifoam compositions useful in particular for the treatment of gastric disorders.
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
CA2177476A1 (en) * 1993-11-30 1995-06-08 Maryellen L. Giger Automated method and system for the alignment and correlation of images from two different modalities
WO1996004128A1 (en) * 1994-08-03 1996-02-15 Voss Gunter M Method or producing coated tablets
US5609883A (en) * 1994-09-16 1997-03-11 Advanced Technology Pharmaceuticals Corporation Compressed tablet transitory lubricant system
GB9523136D0 (en) * 1995-11-11 1996-01-10 Procter & Gamble Silicone-containing powders
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5908636A (en) * 1996-06-28 1999-06-01 Mcneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form containing an antiflatulent
JP3001440B2 (en) * 1996-11-25 2000-01-24 日本電気通信システム株式会社 Virtual LAN method
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
JP2002523358A (en) * 1998-08-25 2002-07-30 プラット，クリス Slow release tablets containing naproxen and pseudoephedrine
FR2803720B1 (en) 2000-01-18 2004-10-22 Roquette Freres DEXTROSE-BASED LOZENGES AND THEIR MANUFACTURING METHOD
US6399591B1 (en) 2000-01-19 2002-06-04 Yung-Shin Pharmaceutical Ind. Co., Ltd. Chargeable pharmaceutical tablets
EP1256347A1 (en) * 2001-05-10 2002-11-13 Swiss Caps Rechte und Lizenzen AG Use of starch for the preparation of an agent for therapeutic treatment
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
US20040185032A1 (en) * 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
EP2363428B1 (en) * 2010-02-23 2014-03-05 Dow Global Technologies LLC Rheology modifier for cement slurries
CN101804199B (en) * 2010-03-30 2012-07-25 四川健能制药有限公司 Pharmaceutical composition used for alimentary canals and application thereof
GB201014041D0 (en) 2010-08-23 2010-10-06 Biofilm Ltd Soluble film
MX2013004095A (en) 2010-12-10 2013-07-17 Dow Corning Granulated foam control composition.
GB201021170D0 (en) 2010-12-10 2011-01-26 Dow Corning Granulated organopolysiloxane products
JP2013103204A (en) * 2011-11-16 2013-05-30 Shin-Etsu Chemical Co Ltd Powder antifoaming agent and method for producing the same
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
MX368363B (en) 2012-06-12 2019-09-30 Procter & Gamble Effervescent dosage form.
JP6026859B2 (en) * 2012-11-16 2016-11-16 楠本化成株式会社 Antifoaming improver for waterborne antifoaming agent
JP5969360B2 (en) * 2012-11-19 2016-08-17 楠本化成株式会社 Defoamer for water-based paint without volatile matter
MA41620A (en) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S PHARMACEUTICAL COMPOSITION CONSISTING OF SIMETHICONE AND OTILONIUM
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
MX2016016587A (en) * 2016-12-14 2018-06-13 Rhein Siegfried Sa De Cv Improved composition of lansoprazole and simeticone and method for preparing same.
US20230248026A1 (en) 2020-07-03 2023-08-10 Arla Foods Amba Neutral instant beverage whey protein powder
CN112044119A (en) * 2020-09-07 2020-12-08 安徽銮威化工科技开发有限公司 Organic silicon defoaming agent for PVC (polyvinyl chloride) and preparation method thereof
CN112263851A (en) * 2020-09-30 2021-01-26 四川健能制药有限公司 Preparation method of simethicone defoaming composition
WO2023089432A1 (en) 2021-11-16 2023-05-25 Johnson & Johnson Consumer Inc. Customizable dosage forms containing simethicone

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA508856A (en) * 1955-01-04 Shell Development Company Non-foaming detergents
US2441098A (en) * 1946-09-09 1948-05-04 Corning Glass Works Methyl siloxane polymers and method of preparation
US2774710A (en) * 1952-12-15 1956-12-18 Organon Pharmaceutical preparation for the treatment of hyperacidity
CA662734A (en) * 1959-07-20 1963-05-07 Hercules Powder Company Defoamer
US3207698A (en) * 1963-02-13 1965-09-21 Nopco Chem Co Composition and method for defoaming aqueous systems
US3304266A (en) * 1963-05-06 1967-02-14 Dow Corning Foam control agents
US3388073A (en) * 1963-12-16 1968-06-11 Nalco Chemical Co Process of defoaming and inhibiting foam formation in aqueous systems
US3326754A (en) * 1965-06-10 1967-06-20 Rexall Drug Chemical Method of relieving gastrointestinal distress with tributyl phosphate
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3849194A (en) * 1966-12-19 1974-11-19 Cpc International Inc Low d.e. starch conversion products
USRE30880E (en) * 1967-03-24 1982-03-09 Grain Processing Corporation Low D.E. starch conversion products
US3528929A (en) * 1967-05-24 1970-09-15 Buckman Labor Inc Defoaming,deaerating,and drainage aid compositions
US3663369A (en) * 1968-02-23 1972-05-16 Grain Processing Corp Hydrolysis of starch
DE1914684B2 (en) * 1969-03-22 1975-12-04 Th. Goldschmidt Ag, 4300 Essen Defoamer emulsion
DE1936126C3 (en) * 1969-07-16 1973-12-06 Bayer Ag, 5090 Leverkusen Defoamer
US3767794A (en) * 1969-11-21 1973-10-23 Richardson Merrell Inc Antifoam preparations and method of preparing same
US3909445A (en) * 1970-03-18 1975-09-30 Mobil Oil Corp Method for reducing foam in water containing systems
US3714068A (en) * 1970-12-28 1973-01-30 Philadelphia Quartz Co Silica
US3705859A (en) * 1970-12-30 1972-12-12 Hercules Inc Method of abating foam formation in aqueous systems
US4298400A (en) * 1971-01-18 1981-11-03 Grain Processing Corporation Low D.E. starch conversion products
GB1378874A (en) * 1971-07-01 1974-12-27 Dow Corning Ltd Foam control substance
BE788249A (en) * 1972-05-15 1973-02-28 Dow Corning SILICONE COMPOSITIONS TO COMBAT FOAMING IN JET DYING PROCESSES
US3784479A (en) * 1972-05-15 1974-01-08 Dow Corning Foam control composition
US4102823A (en) * 1972-12-08 1978-07-25 The Procter & Gamble Company Low and non-phosphate detergent compositions
US4115553A (en) * 1973-12-10 1978-09-19 Armour Pharmaceutical Company Antacid tablets
US3912652A (en) * 1973-12-17 1975-10-14 Dow Corning Defoaming composition useful in jet dyeing
US3959176A (en) * 1974-09-09 1976-05-25 Drew Chemical Corporation Non-foaming dispersing composition
US4127650A (en) * 1975-03-31 1978-11-28 William H. Rorer, Inc. Medicinal simethicone containing composition and its method of production
US4230693A (en) * 1975-04-21 1980-10-28 Armour-Dial, Inc. Antacid tablets and processes for their preparation
US4180485A (en) * 1977-11-02 1979-12-25 The Procter & Gamble Company Spray-dried detergent compositions
CH636123A5 (en) * 1978-06-07 1983-05-13 Ciba Geigy Ag METHOD FOR PRODUCING FOAM-REGULATED DETERGENTS.
US4386106A (en) * 1981-12-01 1983-05-31 Borden, Inc. Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US4698264A (en) * 1982-08-02 1987-10-06 Durkee Industrial Foods, Corp. Particulate composition and process for making same
US4514319A (en) * 1983-03-25 1985-04-30 Union Carbide Corporation Antifoam composition containing hydrocarbon-silicon copolymer, hydrophobic filler and hydrocarbon oil
US4497832A (en) * 1983-04-18 1985-02-05 Warner-Lambert Company Chewing gum composition having enhanced flavor-sweetness
JPS59222209A (en) * 1983-05-30 1984-12-13 Shin Etsu Chem Co Ltd Solid deforming agent
US4581381A (en) * 1983-11-14 1986-04-08 Nabisco Brands, Inc. Soft homogeneous antacid tablet
JPS6142309A (en) * 1984-08-06 1986-02-28 Shin Etsu Chem Co Ltd Powdery defoaming agent
US4590075A (en) * 1984-08-27 1986-05-20 Warner-Lambert Company Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
GB8521956D0 (en) * 1985-09-04 1985-10-09 Unilever Plc Antifoam ingredient
US5004595A (en) * 1986-12-23 1991-04-02 Warner-Lambert Company Multiple encapsulated flavor delivery system and method of preparation
US4804543A (en) * 1987-07-14 1989-02-14 Warner-Lambert Company Novel hydrophilic plasticizing system and chewing gum containing same
US5024937A (en) * 1989-04-06 1991-06-18 Dow Corning Corporation Method for processing aqueous fermentation broths

Also Published As

Publication number Publication date
ATE125170T1 (en) 1995-08-15
JPH03151005A (en) 1991-06-27
CA2026030C (en) 1997-04-01
DE69021007D1 (en) 1995-08-24
US5073384A (en) 1991-12-17
DE69021007T2 (en) 1996-03-21
EP0425450A2 (en) 1991-05-02
EP0425450B1 (en) 1995-07-19
EP0425450A3 (en) 1991-07-10
JPH0815521B2 (en) 1996-02-21

Similar Documents

Publication Publication Date Title
CA2026030A1 (en) Maltodextrin/defoaming composition combinate
CA2101779A1 (en) Defoaming composition
ZA912580B (en) Thiophene sulfonamides useful as carbonic anhydrase inhibitors
CA2149362A1 (en) Pharmaceutical composition based on guar gum coated with simethicone, inassociation with a neutralizing antacid
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
EP0497977A4 (en) Gastric preparation
CA2038672A1 (en) Dosage form for delivering drug to the intestine
AU5124790A (en) Improvements in or relating to devices for administration of drugs or the like
ES2159524T3 (en) PHARMACEUTICAL PREPARATION TO BE ADMINISTERED INSIDE THE RESPIRATORY ROADS.
CA2061917A1 (en) Pediatric effervescent dosage form
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
IL101635A0 (en) Pharmaceutical compositions containing colloidal particles of water insoluble active substances
NZ337418A (en) Paracetamol composition with improved rate of absorption
IS5359A (en) Pharmaceutical composition with vitamin D and calcium, their preparation and use for therapeutic purposes
BR0005801A (en) Compositions containing fat-soluble vitamins
EP0418597A3 (en) Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
CA2046533A1 (en) Treatment of endometriosis
IE790194L (en) Pharmaceutical formulation
CA2033418A1 (en) Pharmaceutical preparation for oral administration in fluid form
DE69414622T2 (en) Streptogramins in purified form, their preparation and pharmaceutical compositions containing them
KR870010082A (en) Guar powder
MY101916A (en) Etoposide oral dosage form.
JPS55153717A (en) Preparation of ubidecarenone soft capsule
Eyanson Diclofenac sodium.
SI0625351T1 (en) Use of Etofibrate and pharmaceutical compositions containing etofibrate in the treatment of diabetic angio- and retinopathy

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed